HM
TEVA icon

HealthCor Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

HealthCor Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-499,640
Closed -$3.76M – 69
2022
Q2 		$3.76M Buy
+499,640
New +$4.35M 0.38% 41
2020
Q2 		– Sell
-1,492,800
Closed -$13.4M – 62
2020
Q1 		$13.4M Buy
+1,492,800
New +$15.3M 0.57% 40
2016
Q2 		– Sell
-419,760
Closed -$22.5M – 49
2016
Q1 		$22.5M Sell
419,760
-570,750
-58% -$33.5M 1.27% 23
2015
Q4 		$65M Buy
+990,510
New +$61.2M 3.95% 9
2015
Q3 		– Sell
-63,200
Closed -$3.73M – 57
2015
Q2 		$3.73M Sell
63,200
-1,086,800
-95% -$67M 0.19% 44
2015
Q1 		$71.6M Buy
1,150,000
+866,000
+305% +$50.4M 3.42% 9
2014
Q4 		$16.3M Buy
+284,000
New +$15.8M 0.91% 34
2014
Q1 		– Sell
-165,200
Closed -$6.62M – 67
2013
Q4 		$6.62M Buy
+165,200
New +$6.5M 0.4% 40

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

HealthCor Management's TEVA Position: Q3 2022 in Review

HealthCor Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2022, closing a stake of 499,640 shares — an estimated $3.76M sold.

HealthCor Management first reported a position in TEVA in Q4 2013 and held it in 8 quarters. The position peaked at $71.6M in Q1 2015. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • HealthCor Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2022 after selling out during the quarter.
  • HealthCor Management sold 499,640 Teva Pharmaceutical Industries Limited shares in Q3 2022, an estimated $3.76M.
  • HealthCor Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2013 and held it in 8 quarters.
  • HealthCor Management's Teva Pharmaceutical Industries Limited position peaked at $71.6M in Q1 2015.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2022.

Based on HealthCor Management's 13F filing for Q3 2022, filed 14 Nov 2022.